Sirous Zeinali

2.0k total citations
112 papers, 1.3k citations indexed

About

Sirous Zeinali is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Sirous Zeinali has authored 112 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 21 papers in Genetics and 15 papers in Hematology. Recurrent topics in Sirous Zeinali's work include Metabolism and Genetic Disorders (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Hemoglobinopathies and Related Disorders (8 papers). Sirous Zeinali is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Hemoglobinopathies and Related Disorders (8 papers). Sirous Zeinali collaborates with scholars based in Iran, United States and Italy. Sirous Zeinali's co-authors include Kayhan Azadmanesh, Ladan Teimoori‐Toolabi, Mahdi Behdani, Masoumeh Azizi, Morteza Karimipoor, Hossein Khanahmad, Yousof Gheisari, Masoud Soleimani, Gholamreza Hassanzadeh‐Ghassabeh and Serge Muyldermans and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sirous Zeinali

104 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sirous Zeinali Iran 18 794 215 202 154 154 112 1.3k
Irina Golovleva Sweden 25 927 1.2× 174 0.8× 284 1.4× 127 0.8× 127 0.8× 78 1.9k
Douglas Vernimmen United Kingdom 21 1.4k 1.8× 197 0.9× 361 1.8× 73 0.5× 127 0.8× 31 1.8k
Eleanor B. Carson-Walter United States 16 861 1.1× 207 1.0× 128 0.6× 127 0.8× 175 1.1× 19 1.4k
Mary Shannon Byers United States 12 842 1.1× 275 1.3× 124 0.6× 123 0.8× 298 1.9× 13 1.5k
Ko Sasaki Japan 21 602 0.8× 93 0.4× 78 0.4× 159 1.0× 207 1.3× 78 1.3k
Rutger W. W. Brouwer Netherlands 20 1.2k 1.5× 189 0.9× 298 1.5× 40 0.3× 145 0.9× 56 1.8k
Masahiro Muto Japan 18 1.4k 1.8× 123 0.6× 405 2.0× 54 0.4× 188 1.2× 54 1.9k
Wouter Korver United States 19 1.0k 1.3× 96 0.4× 176 0.9× 68 0.4× 306 2.0× 26 1.6k
Jason Howitt Australia 23 1.7k 2.1× 541 2.5× 216 1.1× 56 0.4× 208 1.4× 34 2.2k

Countries citing papers authored by Sirous Zeinali

Since Specialization
Citations

This map shows the geographic impact of Sirous Zeinali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sirous Zeinali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sirous Zeinali more than expected).

Fields of papers citing papers by Sirous Zeinali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sirous Zeinali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sirous Zeinali. The network helps show where Sirous Zeinali may publish in the future.

Co-authorship network of co-authors of Sirous Zeinali

This figure shows the co-authorship network connecting the top 25 collaborators of Sirous Zeinali. A scholar is included among the top collaborators of Sirous Zeinali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sirous Zeinali. Sirous Zeinali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sotoodehnejadnematalahi, Fattah, et al.. (2023). Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression. Scientific Reports. 13(1). 1003–1003. 20 indexed citations
2.
Karami, Fatemeh, et al.. (2023). Identification of Novel Mutations in the MMAA and MUT Genes among Methylmalonic Aciduria Families. PubMed. 27(6). 397–403. 1 indexed citations
3.
Vahidnezhad, Hassan, Leila Youssefian, Soheila Sotoudeh, et al.. (2020). Genomics‐based treatment in a patient with two overlapping heritable skin disorders: Epidermolysis bullosa and acrodermatitis enteropathica. Human Mutation. 41(5). 906–912. 12 indexed citations
4.
Youssefian, Leila, Hassan Vahidnezhad, Andrew Touati, et al.. (2018). The genetic basis of hyaline fibromatosis syndrome in patients from a consanguineous background: a case series. BMC Medical Genetics. 19(1). 87–87. 5 indexed citations
5.
Youssefian, Leila, Hassan Vahidnezhad, Amir Hossein Saeidian, et al.. (2018). A novel autosomal recessiveGJB2-associated disorder: Ichthyosis follicularis, bilateral severe sensorineural hearing loss, and punctate palmoplantar keratoderma. Human Mutation. 40(2). 217–229. 12 indexed citations
6.
Abiri, Maryam, et al.. (2015). Molecular Characterization of QDPR Gene in Iranian Families with BH4 Deficiency: Reporting Novel and Recurrent Mutations. JIMD Reports. 21. 123–128. 8 indexed citations
7.
Arezumand, Roghaye, Mahdi Behdani, Reza Mahdian, et al.. (2015). Camel Heavy Chain Polyclonal Antibody Raised Against Recombinant Murine Placental Growth Factor Expressed in Escherichia coli. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 34(2). 126–130. 2 indexed citations
8.
Fard‐Esfahani, Pezhman, et al.. (2014). FAMILIAL DEFECTIVE APOLIPORROTEIN B 100: FREQUENCY OF R3500Q MUTATION OF APOLIPOROTEIN B GENE IN IRANIAN HYPERCHOLESTEROLEMIC PATIENTS. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Mahdian, Reza, et al.. (2013). Comparisons between RT-PCR, real-time PCR, and in vitro globin chain synthesis by α/β ratio calculation for diagnosis of α- from β-thalassemia carriers.. PubMed. 16(4). 217–20. 4 indexed citations
10.
Karimipoor, Morteza, et al.. (2013). FREQUENCY OF ALPHA THALASSEMIA CARRIERS DETECTED IN TEHRAN PREMARRIAGE SCREENING USING MOLECULAR TECHNIQUES. Scientific Journal of Iran Blood Transfus Organ. 9(437). 414–421. 1 indexed citations
11.
Mahdieh, Nejat, et al.. (2012). Screening of OTOF mutations in Iran: A novel mutation and review. International Journal of Pediatric Otorhinolaryngology. 76(11). 1610–1615. 30 indexed citations
12.
Gheisari, Yousof, Kayhan Azadmanesh, Naser Ahmadbeigi, et al.. (2012). Genetic Modification of Mesenchymal Stem Cells to Overexpress CXCR4 and CXCR7 Does Not Improve the Homing and Therapeutic Potentials of These Cells in Experimental Acute Kidney Injury. Stem Cells and Development. 21(16). 2969–2980. 45 indexed citations
13.
Zeinali, Sirous, et al.. (2011). The Occurrence and Contribution of Germline BRCA1/2 Sequence Alterations in Iranian Patients With Breast Cancer. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Karimipoor, Morteza, et al.. (2011). ANALYSIS OF β GLOBIN GENE MUTATIONS AND G γ XMNI POLYMORPHISM IN THALASSEMIA INTERMEDIA PATIENTS REFERRED TO ALI-ASGHAR HOSPITAL, TEHRAN. Scientific Journal of Iran Blood Transfus Organ. 8(130). 20–31. 2 indexed citations
15.
Teimoori‐Toolabi, Ladan, Kayhan Azadmanesh, & Sirous Zeinali. (2010). Selective Suicide Gene Therapy of Colon Cancer Cell Lines Exploiting Fibroblast Growth Factor 18 Promoter. Cancer Biotherapy and Radiopharmaceuticals. 25(1). 105–116. 17 indexed citations
16.
Mahdieh, Nejat, et al.. (2010). Unexpected heterogeneity due to recessive and de novo dominant mutations of GJB2 in an Iranian family with nonsyndromic hearing loss: Implication for genetic counseling. Biochemical and Biophysical Research Communications. 402(2). 305–307. 7 indexed citations
17.
Zeinali, Sirous, et al.. (2010). Molecular study of alpha-thalassemia mutations in Iranian potential carriers. Scientific Journal of Iran Blood Transfus Organ. 7(227). 70–77. 1 indexed citations
18.
Mahdian, Reza, et al.. (2009). Validation and comparison of two quantitative real-time PCR assays for direct detection of DMD/BMD carriers. Clinical Biochemistry. 42(12). 1291–1299. 20 indexed citations
19.
Azizi, Ebrahim, et al.. (2004). CROSS-RESISTANCE TO VINCRISTIN AND ETOPOSIDE IN A SUB LINE OF THE HUMAN BREAST CANCER T47D CELLS SELECTED FOR ADRIAMYCIN-RESISTANCE. Iranian journal of pharmaceutical research. 3(2). 103–107. 1 indexed citations
20.
Farhud, DD, et al.. (2003). "Molecular Analysis of Iranian Patients with Duchenne/Becker Muscular Dystrophies". SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irina Golovleva Breakdown of academic impact, for papers by Douglas Vernimmen Breakdown of academic impact, for papers by Eleanor B. Carson-Walter Breakdown of academic impact, for papers by Mary Shannon Byers Breakdown of academic impact, for papers by Ko Sasaki Breakdown of academic impact, for papers by Rutger W. W. Brouwer Breakdown of academic impact, for papers by Masahiro Muto Breakdown of academic impact, for papers by Wouter Korver Breakdown of academic impact, for papers by Jason Howitt
Rankless by CCL
2026